Melissa Little, PhD, is chief scientist at Murdoch Children’s Research Institute in Australia. She spoke at ASN Kidney Week 2024 on “Understanding, Improving, and Applying Human Pluripotent Stem Cell-Derived Kidney Tissues.” She is also an author of the Kidney Week abstracts “Controlling Proximal Nephron Arrangement and Maturity in Stem Cell-Derived Engineered Kidney Tissue” and “Endosomal Recycling and Proteasomal Degradation of R168H Variant Podocin Contributes to Nephrotic Syndrome Pathophysiology.” Joel Topf, MD, spoke with Dr. Little about her research.